Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
NRGX Gene therapy
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by BooDog: [QB] “Over the past quarter, we have been completing preparations at each of the institutions across the United States that will be participating in the Phase 2 clinical trial of our investigational gene therapy procedure for the treatment of Parkinson’s disease,” said Mr. Mordock. “We expect to announce the start of enrollment in the near future for this important study, which is designed to demonstrate efficacy as well as safety for our novel gene transfer procedure.” [URL=http://www.sec.gov/Archives/edgar/data/356591/000119380508001915/e604107_10q-neurologix.htm]http://www.sec.gov/Archives/edgar/data/356591/000119380508001915/e604107_10q-neu rologix.htm[/URL] On August 12, 2008, Neurologix, Inc. (the “Company”) entered into an Addendum (the “Addendum”), effective as of August 1, 2008, to its Development and Manufacturing Agreement (the “Development Agreement”), dated as of April 27, 2005, with Medtronic, Inc. (“Medtronic”). The Addendum supplements and clarifies the rights and obligations of each of the Company and Medtronic under the Development Agreement in preparation of the Company’s Phase 2 clinical trial for its Parkinson’s disease product. [URL=http://www.sec.gov/Archives/edgar/data/356591/000119380508001962/e604128_8k-neurologix.htm]http://www.sec.gov/Archives/edgar/data/356591/000119380508001962/e604128_8k-neur ologix.htm[/URL] NEUROLOGIX INC(OTC BB: NRGX.OB) Last Trade: 0.74 Trade Time: Aug 15 Change: 0.00 (0.00%) Prev Close: 0.74 Open: 0.73 Bid: 0.63 x 2500 Ask: 0.74 x 2500 1y Target Est: 2.00 Day's Range: 0.73 - 0.74 52wk Range: 0.45 - 1.55 Volume: 716 Avg Vol (3m): 22,725 Market Cap: 20.45M P/E (ttm): N/A EPS (ttm): -0.53 Div & Yield: Now have 1 analyst on board lol... Analyst Opinion Get Analyst Opinion for: RECOMMENDATION SUMMARY* Mean Recommendation (this week): 2 Mean Recommendation (last week): Change: N/A * (Strong Buy) 1.0 - 5.0 (Sell) Coverage initiated on Neurologix by Roth Capital Briefing.com(Fri, Aug 8) http://biz.yahoo.com/a/1/185794.html [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2